Articles

New oncology reimbursements in Belgium

BJMO - volume 8, issue 4, september 2014

Tom Feys MBA, MSc, P. Specenier MD, PhD

Overview of Belgian reimbursement news

(BELG J MED ONCOL 2014;8(3):132)

Read more

New medical treatments in thyroid cancer

BJMO - volume 8, issue 3, july 2014

L. Decoster MD, PhD, F. Cornélis MD, E. Joosens MD, S. Henry MD, P. Specenier MD, PhD, P. Clement MD, PhD, On behalf of the Thyroid Task Force of the BSMO

Thyroid cancers are rare diseases and include types that range from indolent localised differentiated carcinomas to fulminant and lethal anaplastic disease. Until recently, treatment options for advanced or metastatic radio-iodine refractory thyroid cancer were limited. Recently kinase inhibitors targeting angiogenesis and other pathways have shown promising activity.

(BELG J MED ONCOL 2014;8(3):81–6)

Read more

New oncology reimbursements in Belgium

BJMO - volume 8, issue 2, may 2014

Tom Feys MBA, MSc, MBA , P. Specenier MD, PhD

Overview of Belgian reimbursement news.

(BELG J MED ONCOL 2014;8(2):59)

Read more

New oncology reimbursements in Belgium

BJMO - volume 7, issue 4, september 2013

Tom Feys MBA, MSc, P. Specenier MD, PhD

(BELG J MED ONCOL 2013;7(4):133)

Read more

New oncology reimbursements in Belgium

BJMO - volume 7, issue 3, july 2013

Tom Feys MBA, MSc, P. Specenier MD, PhD

Summary

Overview of Belgian reimbursement news.

(BELG J MED ONCOL 2013;7(3):101)

Read more

New oncology reimbursements in Belgium

BJMO - volume 7, issue 2, may 2013

Tom Feys MBA, MSc, P. Specenier MD, PhD

Summary

Overview of Belgian reimbursement news.

(BELG J MED ONCOL 2013;7(2):68)

Read more

New Oncology reimbursements in Belgium

BJMO - volume 7, issue 1, february 2013

P. Specenier MD, PhD, Tom Feys MBA, MSc

(BELG J MED ONCOL 2013;7:34)

Read more